1. Home
  2. MXL vs DAWN Comparison

MXL vs DAWN Comparison

Compare MXL & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$17.84

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$10.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
DAWN
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
MXL
DAWN
Price
$17.84
$10.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$19.80
$27.11
AVG Volume (30 Days)
998.2K
1.8M
Earning Date
04-29-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
46.08
N/A
EPS
N/A
N/A
Revenue
$478,596,000.00
$158,182,000.00
Revenue This Year
$22.10
$47.48
Revenue Next Year
$10.70
$31.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.60
52 Week Low
$8.40
$5.64
52 Week High
$20.82
$13.20

Technical Indicators

Market Signals
Indicator
MXL
DAWN
Relative Strength Index (RSI) 47.13 42.37
Support Level $17.90 $10.07
Resistance Level $18.44 $10.68
Average True Range (ATR) 0.95 0.64
MACD -0.13 -0.20
Stochastic Oscillator 30.28 9.56

Price Performance

Historical Comparison
MXL
DAWN

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: